findmyKOL
Clinical trialNCT01638936CompletedPhase 1/PHASE2Interventional

BT062 in Combination With Lenalidomide or Pomalidomide and Dexamethasone in Patients With Multiple Myeloma

SponsorBiotest Pharmaceuticals CorporationEnrollment64Multiple Myeloma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope

    Duarte, California, United States

  • Usc Norris Comprehensive Cancer Center

    Los Angeles, California, United States

  • Mayo Clinic

    Jacksonville, Florida, United States

  • Memorial Healthcare System

    Pembroke Pines, Florida, United States

  • Emory University Winship Cancer Institute

    Atlanta, Georgia, United States

  • the University of Chicago

    Chicago, Illinois, United States

  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Hackensack University Medical Center

    Hackensack, New Jersey, United States

  • Mount Sinai Medical Center

    New York, New York, United States

  • University of Texas Health Science Center

    San Antonio, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Jul 2012
Primary completion
30 Oct 2018
Completion
30 Oct 2018
Last update posted
23 Jul 2019
Registered enrollment
64
Registry id
NCT01638936

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.